Glycopyrrolate Tabs, USP, 1 mg, 30-count unit dose blister card, FOR INSTITUTIONAL USE ONLY, Rx Only, Packaged by Vangard, Glasgow, KY 42141; NDC 0615-8170-39.
Reported: February 26, 2020 Initiated: January 28, 2020 #D-0850-2020
Product Description
Glycopyrrolate Tabs, USP, 1 mg, 30-count unit dose blister card, FOR INSTITUTIONAL USE ONLY, Rx Only, Packaged by Vangard, Glasgow, KY 42141; NDC 0615-8170-39.
Reason for Recall
Failed Impurities/Degradation Specification: High Out of Specification Results for Individual Unknown Impurity.
Details
- Recalling Firm
- NCS Healthcare of Kentucky Inc
- Units Affected
- 6929 blister cards
- Distribution
- Nationwide in the USA.
- Location
- Glasgow, KY
Frequently Asked Questions
What product was recalled? ▼
Glycopyrrolate Tabs, USP, 1 mg, 30-count unit dose blister card, FOR INSTITUTIONAL USE ONLY, Rx Only, Packaged by Vangard, Glasgow, KY 42141; NDC 0615-8170-39.. Recalled by NCS Healthcare of Kentucky Inc. Units affected: 6929 blister cards.
Why was this product recalled? ▼
Failed Impurities/Degradation Specification: High Out of Specification Results for Individual Unknown Impurity.
Which agency issued this recall? ▼
This recall was issued by the FDA Drug on February 26, 2020. Severity: Moderate. Recall number: D-0850-2020.
Related Recalls
NHTSA Critical
LEXUS 2025: POWER TRAIN:AUTOMATIC TRANSMISSION
LEXUS · 2026-02-18
NHTSA Critical
CADILLAC,CHEVROLET,GMC 2022: POWER TRAIN:AUTOMATIC TRANSMISSION:CONTROL MODULE:SOFTWARE
CADILLAC,CHEVROLET,GMC · 2026-02-13
NHTSA Critical
CHEVROLET,GMC 2020-2022: POWER TRAIN:AUTOMATIC TRANSMISSION:CONTROL MODULE:SOFTWARE
CHEVROLET,GMC · 2026-02-12
NHTSA Critical
CADILLAC 2024: BACK OVER PREVENTION:SOFTWARE
CADILLAC · 2026-02-12
NHTSA Critical
NISSAN 2024-2025: FUEL SYSTEM, GASOLINE:FUEL INJECTION SYSTEM:THROTTLEBODY/MANIFOLD
NISSAN · 2026-02-12